These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7752013)

  • 1. Fatal hemolysis caused by ceftriaxone.
    Lascari AD; Amyot K
    J Pediatr; 1995 May; 126(5 Pt 1):816-7. PubMed ID: 7752013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia.
    Bernini JC; Mustafa MM; Sutor LJ; Buchanan GR
    J Pediatr; 1995 May; 126(5 Pt 1):813-5. PubMed ID: 7752012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome.
    Borgna-Pignatti C; Bezzi TM; Reverberi R
    Pediatr Infect Dis J; 1995 Dec; 14(12):1116-7. PubMed ID: 8745031
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemolysis after treatment with ceftriaxone.
    Scimeca PG; Weinblatt ME; Boxer R
    J Pediatr; 1996 Jan; 128(1):163. PubMed ID: 8551412
    [No Abstract]   [Full Text] [Related]  

  • 5. Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection.
    Moallem HJ; Garratty G; Wakeham M; Dial S; Oligario A; Gondi A; Rao SP; Fikrig S
    J Pediatr; 1998 Aug; 133(2):279-81. PubMed ID: 9709722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reactions during ceftriaxone treatment can cause severe hemolysis.
    Liu W; Yu D
    Pediatr Allergy Immunol; 2014 Feb; 25(1):101-2. PubMed ID: 24118095
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.
    Schuettpelz LG; Behrens D; Goldsmith MI; Druley TE
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):870-2. PubMed ID: 19829151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe intravascular hemolysis associated with interferon treatment for chronic myeloid leukemia.
    Tuckfield A; Metz J; Grigg A
    Am J Hematol; 1996 Sep; 53(1):52-3. PubMed ID: 8813104
    [No Abstract]   [Full Text] [Related]  

  • 9. Ceftriaxone-induced hemolysis.
    Guleria VS; Sharma N; Amitabh S; Nair V
    Indian J Pharmacol; 2013; 45(5):530-1. PubMed ID: 24130395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hemolytic crisis after ceftriaxone administration.
    Goyal M; Donoghue A; Schwab S; Hasbrouck N; Khojasteh S; Osterhoudt K
    Pediatr Emerg Care; 2011 Apr; 27(4):322-3. PubMed ID: 21467885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal Anaphylactic Shock Ceftriaxone-Induced in a 4-Year-Old Child.
    Calapai G; Imbesi S; Ventura-Spagnolo E; Cafeo V; Milone L; Navarra M; Gangemi S
    Pediatr Emerg Care; 2016 Jan; 32(1):32-3. PubMed ID: 25513979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylaxis after first exposure to ceftriaxone.
    Ernst MR; van Dijken PJ; Kabel PJ; Draaisma JM
    Acta Paediatr; 2002; 91(3):355-6. PubMed ID: 12022312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of ceftriaxone-induced haemolysis complicated by acute portal vein thrombosis.
    Ye W; Liu CW
    Chin Med J (Engl); 2011 Jan; 124(1):152-4. PubMed ID: 21362324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asystole after the first dose of ceftriaxone.
    Saritas A; Erbas M; Gonen I; Candar M; Ozturk O; Kandis H; Sezen G
    Am J Emerg Med; 2012 Sep; 30(7):1321.e3-4. PubMed ID: 21855259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of ceftriaxone-induced red blood cell antibodies in pediatric patients with sickle cell disease and human immunodeficiency virus infection.
    Quillen K; Lane C; Hu E; Pelton S; Bateman S
    Pediatr Infect Dis J; 2008 Apr; 27(4):357-8. PubMed ID: 18316983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
    Dinesh D; Dugan N; Carter J
    Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Massive cardiac lipomatosis, an autopsy finding in a patient with sudden death].
    Zamarrón-de Lucas E; García-Fernández E; Carpio C; Alcolea S; Martínez-Abad Y; Álvarez-Sala R
    Med Clin (Barc); 2016 Jun; 146(12):541-3. PubMed ID: 27143526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of Ph negative acute myeloid leukemia in a patient with minor-BCR/ABL positive chronic myeloid leukemia achieving a partial cytogenetic response during tyrosine kinase inhibitor treatment].
    Fujii S; Miura I; Tanaka H
    Rinsho Ketsueki; 2015 Jun; 56(6):681-6. PubMed ID: 26256879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-mediated complications during interferon alpha therapy in chronic myelogenous leukemia.
    Tóthová E; Kafková A; Stecová N; Fricová M; Guman T; Svorcová E
    Neoplasma; 2002; 49(2):91-4. PubMed ID: 12088112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases].
    Zhong XH; Chen H; Yao Y; Zhuo XW; Huang JP; Xiao HJ; Ai Y
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):216-9. PubMed ID: 20426960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.